Screening lead compounds for QT interval prolongation

Drug Discovery Today

Volumn 6, Issue 2, 2001, Pages 78-84

  Netzer, Rainer ^a   Ebneth, Andreas ^a   Bischoff, Ulrike ^a   Pongs, Olaf ^a  

^a Forschungsgesellschaft mbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; DOFETILIDE; HALOPERIDOL; ION CHANNEL; LUBELUZOLE; MIBEFRADIL; POTASSIUM CHANNEL;

CARDIOTOXICITY; CHO CELL; DRUG SCREENING; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HUMAN; NONHUMAN; QT INTERVAL; REVIEW; SPECIES; TOXICITY TESTING; XENOPUS;

EID: 0035142612     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01602-0     Document Type: Review

References (29)

1. QT interval prolongation by non-cardiac drugs: lessons to be learned from recent experiences
2. Acquired QT prolongation: mechanism and implication
3. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia
4. Ion channels: basic sciences and clinical disease
5. Preclinical in vitro cardiac electrophysiology
6. The cardiac ion channels: relevance to management of arrhythmias
7. Drugs that prolong QT interval as an unwanted effect: assessment of their likelihood of inducing hazardous cardiac dysrhythmia
8. Molecular genetics of long-QT syndrome
9. HERG, a human inward rectifier in the voltage-gated potassium channel family
10. kr potassium channels with HERG and is associated with cardiac arrhythmia
11. Time course and voltage dependence of expressed HERG current compared with native 'rapid' delayed rectifier K current during the cardiac ventricular action potential
12. + current in cardiac cells
13. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity
14. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole
15. vLQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel
16. s) cardiac potassium current
17. Spectrum of mutations in long-QT syndrome genes: KvLQT1, HERG, SCN5A, KCNE1 and KCNE2
18. Effects of H1 antihistamines on animal models of QTc prolongation
19. Experimental models of torsade de pointes
20. The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity
21. The preclinical assessment of QT interval prolongation: a comparison of in vitro and in vivo methods
22. QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development
23. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole
24. kr potassium channel
25. Identification of endogenous outward currents in the human embryonic kidney (HEK 293) cell line
26. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte
27. Characterization of the steady-state and dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Dibac4(3)) in model system and cells
28. Cell-based assays and instrumentation for screening ion-channel targets